文献
J-GLOBAL ID:201802249451629906
整理番号:18A0144532
2型糖尿病と心血管疾患患者における下部HbA_1cレベルを標的とした場合の合併症率に対するモデル化増分利益【Powered by NICT】
Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
著者 (7件):
Mostafa S. A.
(Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism)
,
Coleman R. L.
(Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism)
,
Agbaje O. F.
(Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism)
,
Gray A. M.
(Nuffield Department of Population Health, Health Economics Research Centre, University of Oxford)
,
Holman R. R.
(Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism)
,
Holman R. R.
(Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, UK)
,
Bethel M. A.
(Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism)
資料名:
Diabetic Medicine
(Diabetic Medicine)
巻:
35
号:
1
ページ:
72-77
発行年:
2018年
JST資料番号:
D0238C
ISSN:
0742-3071
CODEN:
DIMEEV
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)